Pitavastatin, a cholesterol lowering drug, slashes chemotherapy resistance in breast cancer by obstructing a specific protein ...

CHICAGO, IL - January 08, 2026 - PRESSADVANTAGE - Universal Wellness Roscoe Village provides access to advanced ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Fannin Partners Awarded $300K Phase I SBIR Grant from the National Eye Institute to Advance First-in-Class Non-VEGF-Targeted Therapeutics for Wet AMD ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Ollin Biosciences’ VEGF/Ang2 bispecific antibody has shown superiority over Roche’s Vabysmo (faricimab) in a head-to-head ...

A Korea University research team has discovered that pitavastatin, a widely used lipid-lowering drug, can directly inhibit ...

Rescheduling could let DC legalize marijuana sales; MA anti-cannabis initiative challenge; Study: CBD combats tumors; OH’s $1 ...

These inducement grants were approved by Compass Therapeutics Compensation Committee of the Board of Directors as a material inducement to employment. They were granted outside of the Company’s 2020 ...

Chris McConnell breaks down everything you need to know about clear aligners in 2026, from common problems to hidden truths.

Emerging research suggests women’s cardiovascular systems may respond more strongly to physical activity than men’s, raising ...